Article
Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.
Lung cancer (Amsterdam, Netherlands) - 1 Nov 2008
Pelosi Giuseppe, Sonzogni Angelica, Veronesi Giulia, De Camilli Elisa, Maisonneuve Patrick, Spaggiari Lorenzo, Manzotti Michela, Masullo Michele, Taliento Giulio, Fumagalli Caterina, Bellomi Massimo, Travis William D, Kadivar Maryam, Viale Giuseppe
Abstract excerpt
Detailed studies on the pathologic and molecular features of low-dose computed tomography (LDCT)-detected carcinomas and comparison with unscreened tumors are still lacking. We evaluated the histopathologic features of 89 LDCT-detected lung cancers resected between 2004 and 2006. These tumors occurred within a cohort of 5202 volunteers undergoing annual LDCT, aged > or =50 years, and with a minimum 20 pack-year...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.